PRSS23 and systemic sclerosis: In recent studies, a new subtype of SFRP2+ fibroblasts, SFRP2+PRSS23+ fibroblasts, and SFRP2+SFRP4+ myofibroblasts, a unique subtype of SSc fibroblasts, were identified.